The impact of glutamine supplementation on the short-term mortality of COVID-19 diseased patients admitted to the ICU: A single-blind randomized clinical trial

Omar M. Soliman; Amr M. A. Thabet; Gamal Mohamed Abudahab; Emad Zarief Kamel

doi:10.1080/11101849.2022.2031811

Q3 2022

The impact of glutamine supplementation on the short-term mortality of COVID-19 diseased patients admitted to the ICU: A single-blind randomized clinical trial

Omar M. Soliman · Amr M. A. Thabet · Gamal Mohamed Abudahab · Emad Zarief Kamel

10.1080/11101849.2022.2031811 383 Views 6 Citations

Citations

383

Views

Abstract not available for this publication.

Cite this Article (APA)

Omar, M. S., Amr, M. A. T., Gamal, M. A., Emad, Z. K. (2022). The impact of glutamine supplementation on the short-term mortality of COVID-19 diseased patients admitted to the ICU: A single-blind randomized clinical trial. Egyptian Journal of Anaesthesia. https://doi.org/10.1080/11101849.2022.2031811